Authors:
Kang, SK
Chou, RH
Dodge, RK
Clough, RW
Kang, HSL
Bowen, MG
Steffey, BA
Das, SK
Zhou, SM
Whitehurst, AW
Buckley, NJ
Kim, JH
Joyner, RE
Sarmina, I
Montana, GS
Ingram, SS
Anscher, MS
Citation: Sk. Kang et al., Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method, INT J RAD O, 50(4), 2001, pp. 937-945
Authors:
Alvarez, AA
Axelrod, JR
Whitaker, RS
Isner, PD
Bentley, RC
Dodge, RK
Rodriguez, GC
Citation: Aa. Alvarez et al., Thrombospondin-1 expression in epithelial ovarian carcinoma: Association with p53 status, tumor angiogenesis, and survival in platinum-treated patients, GYNECOL ONC, 82(2), 2001, pp. 273-278
Authors:
Stone, RM
Berg, DT
George, SL
Dodge, RK
Paciucci, PA
Schulman, PP
Lee, EJ
Moore, JO
Powell, BL
Baer, MR
Bloomfield, CD
Schiffer, CA
Citation: Rm. Stone et al., Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine, BLOOD, 98(3), 2001, pp. 548-553
Authors:
Baer, MR
Stewart, GC
Dodge, RK
Leget, G
Sule, N
Mrozek, K
Schiffer, CA
Powel, BL
Kolitz, JE
Moore, JO
Stone, RM
Davey, FR
Carrol, AJ
Larson, RA
Bloomfield, CD
Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580
Authors:
Larson, RA
Dodge, RK
Szatrowski, TP
Frankel, SR
Citation: Ra. Larson et al., Results of recent clinical trials in acute lymphoblastic leukemia by the cancer and leukemia group B, HEMAT BLOOD, 40, 2001, pp. 393-401
Authors:
Maxwell, GL
Risinger, JI
Hayes, KA
Alvarez, AA
Dodge, RK
Barrett, JC
Berchuck, A
Citation: Gl. Maxwell et al., Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers, CLIN CANC R, 6(8), 2000, pp. 2999-3005
Authors:
Elconin, JH
Roberts, KB
Rizzieri, DA
Vermont, C
Clough, RW
Kim, C
Dodge, RK
Prosnitz, LR
Citation: Jh. Elconin et al., Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy, INT J RAD O, 48(4), 2000, pp. 1097-1105
Authors:
Cirisano, FD
Robboy, SJ
Dodge, RK
Bentley, RC
Krigman, HR
Synan, IS
Soper, JT
Clarke-Pearson, DL
Citation: Fd. Cirisano et al., The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma, GYNECOL ONC, 77(1), 2000, pp. 55-65
Authors:
Liu, K
Layfield, LJ
Coogan, AC
Ballo, MS
Bentz, JS
Dodge, RK
Citation: K. Liu et al., Diagnostic accuracy in fine-needle aspiration of soft tissue and bone lesions - Influence of clinical history and experience, AM J CLIN P, 111(5), 1999, pp. 632-640
Authors:
Lee, EJ
George, SL
Caligiuri, M
Szatrowski, TP
Powell, BL
Lemke, S
Dodge, RK
Smith, R
Baer, M
Schiffer, CA
Citation: Ej. Lee et al., Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previouslyuntreated patients 60 years of age or older with acute myeloid leukemia: Results of cancer and leukemia group B study 9420, J CL ONCOL, 17(9), 1999, pp. 2831-2839
Authors:
Byrd, JC
Dodge, RK
Carroll, A
Baer, MR
Edwards, C
Stamberg, J
Qumsiyeh, M
Moore, JO
Mayer, RJ
Davey, F
Schiffer, CA
Bloomfield, CD
Citation: Jc. Byrd et al., Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered, J CL ONCOL, 17(12), 1999, pp. 3767-3775
Authors:
Prosnitz, LR
Maguire, P
Anderson, JM
Scully, SP
Harrelson, JM
Jones, EL
Dewhirst, M
Samulski, TV
Powers, BW
Rosner, GL
Dodge, RK
Layfield, L
Clough, R
Brizel, DM
Citation: Lr. Prosnitz et al., The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy, INT J RAD O, 45(4), 1999, pp. 941-949
Citation: Dm. Brizel et al., Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome, RADIOTH ONC, 53(2), 1999, pp. 113-117
Authors:
Cirisano, FD
Robboy, SJ
Dodge, RK
Bentley, RC
Krigman, HR
Synan, IS
Soper, JT
Clarke-Pearson, DL
Citation: Fd. Cirisano et al., Epidemiologic and surgicopathologic findings of papillary serous and clearcell endometrial cancers when compared to endometrioid carcinoma, GYNECOL ONC, 74(3), 1999, pp. 385-394
Authors:
Czuczman, MS
Dodge, RK
Stewart, CC
Frankel, SR
Davey, FR
Powell, BL
Szatrowski, TP
Schiffer, CA
Larson, RA
Bloomfield, CD
Citation: Ms. Czuczman et al., Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364, BLOOD, 93(11), 1999, pp. 3931-3939
Authors:
Wetzler, M
Dodge, RK
Mrozek, K
Carroll, AJ
Tantravahi, R
Block, AW
Pettenati, MJ
Le Beau, MM
Frankel, SR
Stewart, CC
Szatrowski, TP
Schiffer, CA
Larson, RA
Bloomfield, CD
Citation: M. Wetzler et al., Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience, BLOOD, 93(11), 1999, pp. 3983-3993
Citation: K. Liu et al., Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients, ACT CYTOL, 43(6), 1999, pp. 1027-1033
Citation: K. Liu et al., Logistic regression analysis of high grade spindle cell neoplasms - A fineneedle aspiration cytologic study, ACT CYTOL, 43(4), 1999, pp. 593-600
Authors:
Risinger, JI
Hayes, K
Maxwell, GL
Carney, ME
Dodge, RK
Barrett, JC
Berchuck, A
Citation: Ji. Risinger et al., PTEN mutation in endometrial cancers is associated with favorable clinicaland pathologic characteristics, CLIN CANC R, 4(12), 1998, pp. 3005-3010